McAllister, Peter
Lamerato, Lois
Krasenbaum, Lynda J.
Cohen, Joshua M.
Tangirala, Krishna
Thompson, Stephen
Driessen, Maurice
Casciano, Julian
Dotiwala, Zenobia
Mauskop, Alexander
Funding for this research was provided by:
Teva Pharmaceuticals
Article History
Received: 6 August 2021
Accepted: 10 November 2021
First Online: 20 December 2021
Declarations
:
: The authors confirm that according to local legislation, ethics approval is not required for this retrospective study. The de-identified data used in this study have been recorded and presented in such a manner that subjects cannot be identified and consent to participate from the subjects is therefore not required.
: Not applicable.
: PM has received research support from Amgen, Novartis, Eli Lilly, Teva Pharmaceuticals, and Alder BioPharmaceuticals; and serves as a consultant for Amgen, Novartis, Eli Lilly, Teva Pharmaceuticals, and Alder BioPharmaceuticals. LL is an employee of Henry Ford Health System, with research funding from eMAX Health Systems. JC and ZD are employees of eMAX Health Systems. LJK, ST, and MD are employees of Teva Pharmaceuticals. JMC and KT are former employees of Teva Pharmaceuticals. AM has nothing to disclose.